# FDA recall D-0313-2022

> **SterRx, LLC** · Class II · drug recall initiated 2021-11-12.

## Product

Morphine Sulfate in 5% Dextrose Injection, 100 mg per 100 mL (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-452-01.

## Reason for recall

Lack of Assurance of Sterility

## Distribution

U.S.A. Nationwide

## Key facts

- **Recall number:** D-0313-2022
- **Recalling firm:** SterRx, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2021-11-12
- **Report date:** 2022-01-05
- **Termination date:** 2023-12-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Plattsburgh, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0313-2022

## Citation

> AI Analytics. FDA recall D-0313-2022. Retrieved 2026-06-03 from https://api.ai-analytics.org/recall/D-0313-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*